fMRI evidence of brain reorganization during attention and memory tasks in multiple sclerosis
Introduction
Dysfunction of higher cognitive abilities is a frequent finding in patients with multiple sclerosis (MS) Beatty et al., 1990, Heaton et al., 1985, Peyser et al., 1980. The estimated prevalence ranges from 30% to 70% Heaton et al., 1985, Rao et al., 1991. Neuropsychological impairment in MS typically consists of deficits in memory, attention and speed of information processing.
Whereas detailed information is available on the neuropsychological profile of MS-related cognitive dysfunction, less is known about its pathophysiology. Although previous studies have shown that the extent and severity of the macroscopic and microscopic brain changes seen on conventional and non-conventional magnetic resonance imaging (MRI) are related to neuropsychologic measures of cognitive performance in MS Comi et al., 1995, Huber et al., 1992, Rovaris et al., 2002, Swirsky-Sacchetti et al., 1992, van Buchem et al., 1998, MRI findings leave cognitive dysfunction in MS largely unexplained.
Useful information on MS-related cognitive decline has come from functional imaging studies including positron emission tomography (PET) and single photon emission computed tomography (SPECT) showing a relation between reduced cerebral blood flow and metabolism in specific brain areas and cognitive dysfunction Blinkenberg et al., 2000, Brooks et al., 1984, Paulesu et al., 1996, Pozzilli et al., 1991. These studies, however, have assessed cerebral blood flow or metabolism at rest, when neural activity does not necessarily correspond to task-related neural activity. Cognitive behavior is tested in a separate session using clinical tests that have poor neuroanatomic specificity, and then compared with indices of brain function over large brain regions, resulting in modest imaging–behavior relations.
Changes in brain activity related to specific cognitive tasks can also be studied with blood oxygenation level dependent (BOLD) functional MRI (fMRI), a technique with relatively high spatial and temporal resolution. An fMRI study on patients with recently diagnosed MS has described altered cortical activation during a sustained attention task (Staffen et al., 2002). The investigators interpreted this activation pattern, accompanied by intact neuropsychological performance, as a compensatory mechanism, expression of neuronal plasticity during the early stages of the disease. Altered brain activation patterns have also been found in patients with MS and reduced attentional performance (Penner et al., 2001). This study nevertheless gave no information on the relationship between brain functional changes and the extent of macroscopic brain lesions (disease burden) in MS. Others failed to find a correlation between brain functional changes during the counting Stroop test in patients with MS and the whole brain matter lesion load or the regional lesion load. In contrast, they found a relation between activation changes in the prefrontal cortices and brain atrophy (Parry et al., 2003). Several fMRI data on motor function have showed a strong correlation between the extent of changes in fMRI activation and the MRI lesion burden, suggesting that functional changes in cortical and subcortical motor-related areas can limit impairment secondary to brain damage in MS Pantano et al., 2002a, Pantano et al., 2002b, Reddy et al., 2002, Rocca et al., 2002.
In this study, using fMRI, we investigated multiple cognitive functions including sustained attention, information processing speed, working memory and memory retrieval in patients with relapsing-remitting MS (RRMS) with no or mild overall cognitive impairment. We compared activation patterns during the Paced Auditory Serial Addition Test (PASAT) and a recall task, in patients and matched healthy subjects. We also determined whether fMRI activation changes in patients depended on the extent of macroscopic brain tissue damage as measured on conventional MRI.
Section snippets
Subjects
Twenty-two right-handed patients with RRMS (Lublin and Reingold, 1996) (14 women and 8 men aged between 22 and 50 years, median age 30.5; median disease duration 9 years, range 1–16) participated in the study. Inclusion criteria were the following: no or mild overall cognitive impairment defined as a Mini Mental Status Examination (MMSE) (Folstein et al., 1975) score higher than 26; no concomitant therapy with antidepressant, psychoactive or corticosteroid drugs; no history of alcohol or drug
Neuropsychological and conventional MRI data
In our population of 22 patients, neither the SDMT nor the WLG scores differed significantly from the corresponding scores in controls. But patients had significantly lower scores at the SRT, SPART, and PASAT (Table 1).
When we used the cut-off scores obtained from healthy subjects, of the 22 patients, 14 (63.6%) had an impairment of the SRT; 11 (50%) of the SPART; 10 (45.4%) of the PASAT 2 s; 9 (40.9%) of the SDMT; and 5 (22.7%) of the WLG. Of the 22 patients, 4 therefore had no cognitive
Discussion
Consistent with previous studies, despite their mild clinical disability, most of the patients with MS we studied (18 of 22) had cognitive impairment Amato et al., 1995, van den Burg et al., 1987. Only four patients showed no cognitive dysfunction. In contrast with others, we found no significant correlation between neuropsychological measures and disease burden as measured by T2LL Rao et al., 1989b, Sperling et al., 2001, Swirsky-Sacchetti et al., 1992. One explanation for this finding is our
Acknowledgements
We thank Professors Cesare Fieschi and Gian Luigi Lenzi for their continuous support, and Valter Nucciarelli for his technical assistance.
This work was supported by MURST “Progetto Giovani Ricercatori” and Ministero della Salute (RF01.167), Italy.
References (47)
- et al.
Brain regions differentially involved in remembering what and when: a PET study
Neuron
(1997) - et al.
Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple sclerosis
J. Neurol. Sci.
(1995) - et al.
Common regions of the human frontal lobe recruited by diverse cognitive demands
Trends Neurosci.
(2000) - et al.
“Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician
J. Psychiatr. Res.
(1975) - et al.
Analysis of fMRI time-series revisited
Neuroimage
(1995) - et al.
Detecting activations in PET and fMRI: levels of inference and power
Neuroimage
(1996) - et al.
Quantification of MRI lesion load in multiple sclerosis: a comparison of three computer-assisted techniques
Magn. Reson. Imaging
(1996) - et al.
Contribution of corticospinal tract damage to cortical motor reorganization after a single clinical attack of multiple sclerosis
Neuroimage
(2002) - et al.
Functional basis of memory impairment in multiple sclerosis: a[18F]FDG PET study
Neuroimage
(1996) - et al.
Relationship between corpus callosum atrophy and cerebral metabolic asymmetries in multiple sclerosis
J. Neurol. Sci.
(1992)
Cognitive dysfunction in patients with mildly disabling relapsing-remitting multiple sclerosis: an exploratory study with diffusion tensor MR imaging
J. Neurol. Sci.
Cognitive impairment in early-onset multiple sclerosis. Pattern, predictors, and impact on everyday life in a 4-year follow-up
Arch. Neurol.
Brain regions associated with episodic retrieval in normal aging and Alzheimer's disease
Neurology
Clinical and demographic predictors of cognitive performance in multiple sclerosis. Do diagnostic type, disease duration, and disability matter?
Arch. Neurol.
Cortical cerebral metabolism correlates with MRI lesion load and cognitive dysfunction in MS
Neurology
Patterns of brain activation in people at risk for Alzheimer's disease
N. Engl. J. Med.
Studies on regional cerebral oxygen utilisation and cognitive function in multiple sclerosis
J. Neurol. Neurosurg. Psychiatry
Imaging cognition II: an empirical review of 275 PET and fMRI studies
J. Cogn. Neurosci.
Neural bases of learning and memory: functional neuroimaging evidence
Curr. Opin. Neurol.
Functional magnetic resonance imaging of working memory impairment after traumatic brain injury
J. Neurol. Neurosurg. Psychiatry
Changes in the normal appearing brain tissue and cognitive impairment in multiple sclerosis
J. Neurol. Neurosurg. Psychiatry
The Multiple Sclerosis Functional Composite Measure (MSFC): an integrated approach to MS clinical outcome assessment. National MS Society Clinical Outcomes Assessment Task Force
Mult. Scler.
Neuropsychological findings in relapsing-remitting and chronic-progressive multiple sclerosis
J. Consult. Clin. Psychol.
Cited by (261)
Disease phenotype prediction in multiple sclerosis
2023, iScienceEffect of deep gray matter atrophy on information processing speed in early relapsing-remitting multiple sclerosis
2023, Multiple Sclerosis and Related DisordersTRACking health behaviors in people with Multiple Sclerosis (TRAC-MS): Study protocol and description of the study sample
2022, Contemporary Clinical Trials CommunicationsCitation Excerpt :Our meta-analytic review of cognitive dysfunction in multiple sclerosis [10], along with more recent reviews [21–23], reveals a large effect size (g = -0.515) for working memory impairment in PwMS compared to healthy controls. Furthermore, neuroimaging investigations of working memory tasks in PwMS unequivocally show the lack of load-dependent modulation of the prefrontal-parietal circuitry [24–27]. Interventions to increase physical activity are some of the few behavioral treatment options available to improve cognitive functioning—specifically for the domain of working memory.
Applications of deep learning techniques for automated multiple sclerosis detection using magnetic resonance imaging: A review
2021, Computers in Biology and Medicine